Clay B Siegall Immunome Inc. (IMNM) insider trading activity

IMNM Quotes by TradingView

Clay B Siegall is President and CEO of Immunome Inc.. Currently has a direct ownership of 419,636 shares of IMNM, which is worth approximately $5.05 Million. The most recent transaction as insider was on May 21, 2024, when has been sold 20,434 shares (Common Stock) at a price of $13.78 per share, resulting in proceeds of $281,580. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 420K
31.29% 3M change
n/a 12M change
Total Value Held $5.05 Million

CLAY B SIEGALL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
BUY
Open market or private purchase
$281,580 $13.78 p/Share
20,434 Added 4.64%
419,636 Common Stock
May 20 2024
BUY
Open market or private purchase
$1,106,763 $13.91 p/Share
79,566 Added 16.62%
399,202 Common Stock
Oct 02 2023
BUY
Open market or private purchase
$999,995 $5.91 p/Share
169,204 Added 34.61%
319,636 Common Stock

Also insider at

SGEN
Seagen Inc. Healthcare
President & CEO
NRIX
Nurix Therapeutics, Inc. Healthcare
Director
TALS
Talaris Therapeutics, Inc. Healthcare
Director
STTK
Shattuck Labs, Inc. Healthcare
CBS

Clay B Siegall

President and CEO
Bothell, WA

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMNM